Clinical Trial Update: An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

View source ↗

Summary

An observational study evaluating the combination of rituximab and methotrexate in participants with active rheumatoid arthritis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rituxan (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED